Karachi: Abbott Laboratories (Pakistan) Limited announced the appointment of Mr. Brian William Jordan as a new Director, effective November 25, 2025.

The company communicated this development to the certificate holders of the exchange, highlighting the leadership change within its board. Mr. Jordan's appointment is part of the company's ongoing efforts to enhance its governance and strategic oversight.

According to information available from the Pakistan Stock Exchange (PSX), Abbott Laboratories is classified under the designated market category of the pharmaceutical sector.

The company expressed its commitment to keeping stakeholders informed and ensuring a seamless transition within its board structure.